{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:17:31Z","timestamp":1778116651087,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.leukres.2026.108180","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:12:21Z","timestamp":1770016341000},"page":"108180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clonal hematopoiesis and age-associated degenerative disorders"],"prefix":"10.1016","volume":"162","author":[{"given":"Ioannis","family":"Chanias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-5081","authenticated-orcid":false,"given":"Michael","family":"Doulberis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Bonadies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.leukres.2026.108180_bib1","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.leukres.2026.108180_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacbts.2019.08.006","article-title":"Clonal hematopoiesis: a new step linking inflammation to heart failure","volume":"5","author":"Yura","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"issue":"2","key":"10.1016\/j.leukres.2026.108180_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/rheumatology\/kev294","article-title":"Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study","volume":"55","author":"Mekinian","year":"2016","journal-title":"Rheumatol. (Oxf. )"},{"issue":"18","key":"10.1016\/j.leukres.2026.108180_bib4","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood.2020010163","article-title":"CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease","volume":"138","author":"Hecker","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108180_bib5","first-page":"1606","article-title":"Clonal hematopoiesis and nonhematologic disorders","author":"Jaiswal","year":"2020","journal-title":"Blood 136(14"},{"issue":"8","key":"10.1016\/j.leukres.2026.108180_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2022.12.001","article-title":"Clonal hematopoiesis and inflammation - the perpetual cycle","volume":"33","author":"Avagyan","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"5","key":"10.1016\/j.leukres.2026.108180_bib7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2026.108180_bib8","article-title":"Autoimmune disease in CMML-the chicken or the egg?","volume":"33","author":"Ambinder","year":"2020","journal-title":"Best. Pr. Res Clin. Haematol."},{"issue":"15","key":"10.1016\/j.leukres.2026.108180_bib9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.19.01823","article-title":"Integrating the \"Immunome\" in the stratification of myelodysplastic syndromes and future clinical trial design","volume":"38","author":"Winter","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.leukres.2026.108180_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133296","article-title":"Behalf of the Swiss Mds study, myelodysplastic syndromes in the postgenomic era and future perspectives for precision medicine","volume":"13","author":"Chanias","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.leukres.2026.108180_bib11","article-title":"Inflammasome activation in myeloid malignancies-friend or foe?","volume":"9","author":"Andina","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"43","key":"10.1016\/j.leukres.2026.108180_bib12","doi-asserted-by":"crossref","first-page":"73483","DOI":"10.18632\/oncotarget.19008","article-title":"Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions","volume":"8","author":"Valent","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.leukres.2026.108180_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2026.108180_bib14","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"39","key":"10.1016\/j.leukres.2026.108180_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/EDBK_239083","article-title":"CHIP, CCUS, and other acronyms: definition, implications, and impact on practice","author":"DeZern","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"25","key":"10.1016\/j.leukres.2026.108180_bib17","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.leukres.2026.108180_bib18","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2016-07-728766","article-title":"Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes","volume":"128","author":"Greenberg","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108180_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-042320-034052","article-title":"Precision medicine in low- and middle-income countries","volume":"17","author":"Radich","year":"2022","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.leukres.2026.108180_bib20","first-page":"299","article-title":"The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)","author":"Malcovati","year":"2015","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program 2015"},{"issue":"2","key":"10.1016\/j.leukres.2026.108180_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.leukres.2026.108180_bib22","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.leukres.2026.108180_bib23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41591-025-03499-9","article-title":"Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody","volume":"31","author":"Braun","year":"2025","journal-title":"Nat. Med"},{"issue":"13","key":"10.1016\/j.leukres.2026.108180_bib24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa2402730","article-title":"Aggressive Lymphoma after CD19 CAR T-cell therapy","volume":"391","author":"Kobbe","year":"2024","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.leukres.2026.108180_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ncb3346","article-title":"Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal","volume":"18","author":"Pietras","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108180_bib26","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","article-title":"Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNgamma signaling","volume":"28","author":"Hormaechea-Agulla","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.leukres.2026.108180_bib27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2018.03.025","article-title":"Loss of Dnmt3a immortalizes hematopoietic stem cells in vivo","volume":"23","author":"Jeong","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.leukres.2026.108180_bib29","first-page":"24","article-title":"Approach, clinical implications and management of clonal cytopenia of undetermined significance","volume":"14","author":"Chanias","year":"2022","journal-title":"Health Oncol. Hematol."},{"issue":"104","key":"10.1016\/j.leukres.2026.108180_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002191","article-title":"Diabetes impairs hematopoietic stem cell mobilization by altering niche function","volume":"3","author":"Ferraro","year":"2011","journal-title":"Sci. Transl. Med"},{"issue":"10","key":"10.1016\/j.leukres.2026.108180_bib31","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1172\/JCI57559","article-title":"ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice","volume":"121","author":"Murphy","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.leukres.2026.108180_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108326","article-title":"TET2-loss-of-function-driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity","volume":"33","author":"Fuster","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.leukres.2026.108180_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"issue":"6327","key":"10.1016\/j.leukres.2026.108180_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.leukres.2026.108180_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic Interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.leukres.2026.108180_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal hematopoiesis and cardiovascular disease","volume":"123","author":"Sano","year":"2018","journal-title":"Circ. Res"},{"issue":"8","key":"10.1016\/j.leukres.2026.108180_bib37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-Mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1beta\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.leukres.2026.108180_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exphem.2019.11.008","article-title":"Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients","volume":"80","author":"Zhang","year":"2019","journal-title":"Exp. Hematol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108180_bib39","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/rheumatology\/keaa282","article-title":"M. on behalf, Clonal haematopoiesis is increased in early onset in systemic sclerosis","volume":"59","author":"Ricard","year":"2020","journal-title":"Rheumatol. (Oxf. )"},{"issue":"8","key":"10.1016\/j.leukres.2026.108180_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-018-0107-2","article-title":"Clonal hematopoiesis in patients with rheumatoid arthritis","volume":"8","author":"Savola","year":"2018","journal-title":"Blood Cancer J."},{"issue":"11","key":"10.1016\/j.leukres.2026.108180_bib41","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1093\/rheumatology\/keac108","article-title":"Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)","volume":"61","author":"David","year":"2022","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.leukres.2026.108180_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.873896","article-title":"Clonal hematopoiesis at the crossroads of inflammatory bowel diseases and hematological malignancies: a biological link?","volume":"12","author":"Cumbo","year":"2022","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2026.108180_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood.2021013531","article-title":"C. BLood Institute Trans-omics for Precision Medicine, Association of clonal hematopoiesis with chronic obstructive pulmonary disease","volume":"139","author":"Miller","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2026.108180_bib44","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","article-title":"Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking","volume":"34","author":"Dawoud","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2026.108180_bib45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11899-018-0463-9","article-title":"Disordered Immune Regulation and its Therapeutic Targeting in Myelodysplastic Syndromes","volume":"13","author":"Ivy","year":"2018","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.leukres.2026.108180_bib46","article-title":"The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification","volume":"13","author":"Peng","year":"2022","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108180_bib47","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41416-022-02084-y","article-title":"Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy","volume":"128","author":"Wang","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"20","key":"10.1016\/j.leukres.2026.108180_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011049","article-title":"Immune checkpoint inhibitor therapy and associations with clonal hematopoiesis","volume":"25","author":"Singh","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccell.2025.09.011","article-title":"TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors","volume":"44","author":"Herbrich","year":"2026","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib50","first-page":"84","article-title":"Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort","volume":"10","author":"Jaber Chehayeb","year":"2024","journal-title":"CardioOncology"},{"key":"10.1016\/j.leukres.2026.108180_bib51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","article-title":"Age and age-related diseases: role of inflammation triggers and cytokines","volume":"9","author":"Rea","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.leukres.2026.108180_bib52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","article-title":"An inflammatory environment containing TNFalpha favors Tet2-mutant clonal hematopoiesis","volume":"59","author":"Abegunde","year":"2018","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40364-022-00418-9","article-title":"The Wnt\/beta-catenin signalling pathway in Haematological Neoplasms","volume":"10","author":"Yu","year":"2022","journal-title":"Biomark. Res"},{"issue":"7","key":"10.1016\/j.leukres.2026.108180_bib54","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201544","article-title":"Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS","volume":"218","author":"Trowbridge","year":"2021","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.leukres.2026.108180_bib55","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nri3757","article-title":"SMOCs: supramolecular organizing centres that control innate immunity","volume":"14","author":"Kagan","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108180_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: the release of damage-associated molecular patterns and its physiological relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.leukres.2026.108180_bib57","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2026.108180_bib58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"issue":"1-2","key":"10.1016\/j.leukres.2026.108180_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11693-015-9161-2","article-title":"TGF-beta signaling and its role in the regulation of hematopoietic stem cells","volume":"9","author":"Vaidya","year":"2015","journal-title":"Syst. Synth. Biol."},{"issue":"4","key":"10.1016\/j.leukres.2026.108180_bib60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","article-title":"Role of transforming growth factor-beta superfamily signaling pathways in human disease","volume":"1782","author":"Gordon","year":"2008","journal-title":"Biochim Biophys. Acta"},{"issue":"8","key":"10.1016\/j.leukres.2026.108180_bib61","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/jnr.21072","article-title":"Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?","volume":"84","author":"Lee","year":"2006","journal-title":"J. Neurosci. Res"},{"issue":"5","key":"10.1016\/j.leukres.2026.108180_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41590-020-0663-z","article-title":"Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs","volume":"21","author":"Muto","year":"2020","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108180_bib63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ni0816-1005d","article-title":"Erratum: methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity","volume":"17","author":"Li","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.leukres.2026.108180_bib64","article-title":"Insights into the role of DNA methylation in immune cell development and autoimmune disease","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"16","key":"10.1016\/j.leukres.2026.108180_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164908","article-title":"Myeloid-derived suppressor cells: new insights into the pathogenesis and therapy of MDS","volume":"11","author":"Velegraki","year":"2022","journal-title":"J. Clin. Med"},{"issue":"8","key":"10.1016\/j.leukres.2026.108180_bib66","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.stem.2024.05.010","article-title":"Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging","volume":"31","author":"Jakobsen","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"7706","key":"10.1016\/j.leukres.2026.108180_bib67","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","article-title":"Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host","volume":"557","author":"Meisel","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.leukres.2026.108180_bib68","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/ajh.27322","article-title":"miR-146a(-\/-) mice model reveals that NF-kappaB inhibition reverts inflammation-driven myelofibrosis-like phenotype","volume":"99","author":"Cuenca-Zamora","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"ement 1","key":"10.1016\/j.leukres.2026.108180_bib69","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood-2022-170761","article-title":"The effect of clonal hematopoiesis of indeterminate potential (CHIP) and aspirin on clinical outcomes in the healthy elderly: a sub-study of the aspirin in reducing events in the elderly (ASPREE) randomized controlled trial","volume":"140","author":"McQuilten","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2026.108180_bib70","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood.2022016835","article-title":"Aging drives Tet2+\/- clonal hematopoiesis via IL-1 signaling","volume":"141","author":"Caiado","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib71","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1038\/s41467-023-43697-y","article-title":"Clonal hematopoiesis related TET2 loss-of-function impedes IL1beta-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells","volume":"14","author":"McClatchy","year":"2023","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.leukres.2026.108180_bib72","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","article-title":"Inhibition of interleukin-1beta and reduction in atherothrombotic cardiovascular events in the CANTOS Trial","volume":"76","author":"Everett","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib73","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1038\/s41467-021-26093-2","article-title":"TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis","volume":"12","author":"Tulstrup","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.leukres.2026.108180_bib74","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/stem.493","article-title":"Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells","volume":"28","author":"Chung","year":"2010","journal-title":"Stem Cells"},{"issue":"7673","key":"10.1016\/j.leukres.2026.108180_bib75","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nature23876","article-title":"Ascorbate regulates haematopoietic stem cell function and leukaemogenesis","volume":"549","author":"Agathocleous","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2026.108180_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clnesp.2021.10.014","article-title":"Enriched clonal hematopoiesis in seniors with dietary vitamin C inadequacy","volume":"46","author":"Chen","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"issue":"6","key":"10.1016\/j.leukres.2026.108180_bib77","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13148-019-0739-5","article-title":"Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: normalization of plasma vitamin C induces epigenetic changes","volume":"11","author":"Gillberg","year":"2019","journal-title":"Clin. Epigenet."},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/leu.2017.171","article-title":"Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia","volume":"32","author":"Mingay","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2026.108180_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2020.09.197","article-title":"Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis","volume":"91","author":"SanMiguel","year":"2020","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108180_bib81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-020-00864-8","article-title":"Mechanisms and rejuvenation strategies for aged hematopoietic stem cells","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108180_bib82","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cellsig.2015.02.025","article-title":"Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory- and immune-related disorders","volume":"27","author":"Bahia","year":"2015","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.leukres.2026.108180_bib83","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/2047487320906305","article-title":"Comparison of Swiss and European risk algorithms for cardiovascular prevention in Switzerland","volume":"28","author":"Beuret","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108180_bib84","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1515\/cclm-2015-0871","article-title":"Why are clinical practice guidelines not followed?","volume":"54","author":"Barth","year":"2016","journal-title":"Clin. Chem. Lab Med"},{"issue":"24","key":"10.1016\/j.leukres.2026.108180_bib85","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/eurheartj\/ehm520","article-title":"Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study","volume":"28","author":"Geller","year":"2007","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.leukres.2026.108180_bib86","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2018-08-867333","article-title":"The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis","volume":"133","author":"Cargo","year":"2019","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521262600024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521262600024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:37:08Z","timestamp":1772872628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521262600024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":86,"alternative-id":["S014521262600024X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108180","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal hematopoiesis and age-associated degenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108180"}}